<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00252</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=21 g=1 f=1 --> (3) Evans, H.J. ``Cytological Methods for Detecting  <!-- PJG 0012 frnewline --> Chemical Mutagens.'' Chemical Mutagens: Principles and Methods  <!-- PJG 0012 frnewline --> for Their Detection, Vol. 4. Ed. A. Hollaender (New York and  <!-- PJG 0012 frnewline --> London: Plenum Press, 1976) pp. 1&hyph;29.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (4) Heddle, J.A.,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> ``The Induction of Micronuclei as  <!-- PJG 0012 frnewline --> a Measure of Genotoxicity. A Report of the U.S. Environmental  <!-- PJG 0012 frnewline --> Protection Agency Gene-Tox Program.'' Mutation Research, 123:61&hyph;118 (1983).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (5) Preston, J.R.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> et al.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> ``Mammalian  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> In Vivo  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=3 --> In Vitro  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Cytogenetics Assays: Report of the Gene-Tox Program.'' Mutation  <!-- PJG 0012 frnewline --> Research, 87:143&hyph;188 (1981).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (6) Schmid, W. ``The micronucleus test for cytogenetic  <!-- PJG 0012 frnewline --> analysis'', Chemical Mutagens, Principles and Methods for their  <!-- PJG 0012 frnewline --> Detection. Vol. 4 Hollaender A, (Ed. A ed. (New York and London:  <!-- PJG 0012 frnewline --> Plenum Press, (1976) pp. 31&hyph;53.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (7) Tice, R.E., and Al Pellom ``User's guide: Micronucleus  <!-- PJG 0012 frnewline --> assay data management and analysis system'', NTIS Order no. PB&hyph;90&hyph;212&hyph;598AS.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;79.65  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> In vivo sister chromatid exchange assay.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Purpose.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> in vivo  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> sister chromatid exchange (SCE)  <!-- PJG 0012 frnewline --> assay detects the ability of a chemical to enhance the exchange  <!-- PJG 0012 frnewline --> of DNA between two sister chromatids of a duplicating chromosome.  <!-- PJG 0012 frnewline --> The most commonly used assays employ mammalian bone marrow cells  <!-- PJG 0012 frnewline --> or peripheral blood lymphocytes, often from rodent species.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Definitions.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> For the purposes of this section, the  <!-- PJG 0012 frnewline --> following definitions apply:  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> C-metaphase  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> means a state of arrested cell growth typically seen  <!-- PJG 0012 frnewline --> after treatment with a spindle inhibitor,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> i.e.,  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> colchicine.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sister chromatid exchange  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> means a reciprocal interchange of the  <!-- PJG 0012 frnewline --> two chromatid arms within a single chromosome. This exchange is  <!-- PJG 0012 frnewline --> visualized during the metaphase portion of the cell cycle and  <!-- PJG 0012 frnewline --> presumably requires the enzymatic incision, translocation and  <!-- PJG 0012 frnewline --> ligation of at least two DNA helices.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (c)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test method_ <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Principle of the test method.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) Groups of rodents are exposed by the inhalation route  <!-- PJG 0012 frnewline --> for a minimum of 6 hours/day over a period of not less than 28  <!-- PJG 0012 frnewline --> days to three or more concentrations of a test substance in air.  <!-- PJG 0012 frnewline --> Groups of animals are sacrificed at the end of the exposure  <!-- PJG 0012 frnewline --> period and blood lymphocyte cell cultures are prepared from study  <!-- PJG 0012 frnewline --> animals. Cell growth is suspended after a time and cells are  <!-- PJG 0012 frnewline --> harvested, fixed and stained before scoring for SCEs.  <!-- PJG 0012 frnewline --> Researchers may need to run a trial at the highest tolerated  <!-- PJG 0012 frnewline --> concentration of the test atmosphere to optimize the sample  <!-- PJG 0012 frnewline --> collection time for second division metaphase cells.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) This assay may be done separately or in combination  <!-- PJG 0012 frnewline --> with the subchronic toxicity study, pursuant to the provisions in  <!-- PJG 0012 frnewline --> &sect;79.62.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Description.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) The method described here employs peripheral blood  <!-- PJG 0012 frnewline --> lymphocytes (PBL) of laboratory rodents exposed to the test  <!-- PJG 0012 frnewline --> atmosphere.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) Within twenty-four hours of the last exposure, test  <!-- PJG 0012 frnewline --> animal lymphocytes are obtained by heart puncture and duplicate  <!-- PJG 0012 frnewline --> cell cultures are started for each animal. Cultures are grown in  <!-- PJG 0012 frnewline --> bromo-deoxyuridine (BrdU), and then a spindle inhibitor (e.g.,  <!-- PJG 0012 frnewline --> colchicine) is added to arrest cell growth. Cells are harvested,  <!-- PJG 0012 frnewline --> fixed, and stained and their chromosomes are scored for SCEs.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (3)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Species and strain.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The rat is the recommended test  <!-- PJG 0012 frnewline --> animal. Other rodent species may be used in this assay, but use  <!-- PJG 0012 frnewline --> of that species will be justified by the tester.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (4)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Animal number and sex.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> At least five female and five  <!-- PJG 0012 frnewline --> male animals per experimental and control group shall be used.  <!-- PJG 0012 frnewline --> The use of a single sex or different number of animals shall be  <!-- PJG 0012 frnewline --> justified.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            